news

Phase II Malaria vaccine trial begins in Thailand

1 February 2023

The Mahidol Oxford Tropical Medicine Research Unit (MORU) has begun a Phase II trial to demonstrate that R21/matrix M is well-tolerated and immunogenic when administered with the antimalarial drug combination.

New genetic mutation linked to rare conditions

30 January 2023

Researchers from Wellcome Centre for Human Genetics at the Nuffield Department of Medicine, have discovered that a rare type of genetic variant can be responsible for two well-known skeletal disorders.

NDM student Romain Guyon awarded the 2022 Michelson Prize

25 January 2023

DPhil student at the Jenner Institute, Romain Guyon is among the researchers who received the 2022 Michelson Prizes: Next Generation Grants, announced by Michelson Medical Research Foundation and Human Immunome Project.

Essential research by COI improves understanding of COVID

20 January 2023

Since the start of the pandemic, the CAMS-Oxford Institute (COI) has carried out 11 projects to better understand COVID-19, resulting in 21 published research articles.

The University of Oxford signs MoU with Diamond Light Source

12 January 2023

A new Memorandum of Understanding (MoU) to facilitate collaboration in the field of pandemic preparedness and to promote further cooperation between the University of Oxford and Diamond Light Source, the UK’s national synchrotron has been agreed upon.

Sarah Gilbert awarded 2023 King Faisal Prize

10 January 2023

Professor Dame Sarah Gilbert, the Saïd Chair of Vaccinology in the Nuffield Department of Medicine has been selected to receive King Faisal Prize for Medicine for 2023, along with Professor Dan Barouch of Harvard Medical School.

Three NDM researchers awarded Associate Professorships

5 January 2023

We are delighted to announce that three researchers have been awarded the Associate Professor title, in recognition of their research achievements, contribution to teaching, and contribution to the general work of the Nuffield Department of Medicine.

Oxford Ebola vaccine manufactured and shipped in record time

16 December 2022

More than 40,000 doses of Oxford’s Ebola vaccine have been manufactured by Serum Institute of India (SII) in just 60 days and doses shipped to Uganda.

Study opens a pathway to better diagnosis and treatment of autoimmune diseases

9 December 2022

A study published in Nature by researchers from Washington University School of Medicine in St. Louis, Stanford University School of Medicine and Oxford University have developed a way to find the crucial protein fragment that drives autoimmunity, as well as the immune cells that respond to it.

Oxford’s RECOVERY trial team amongst MRC‘s Outstanding Team Impact prize finalists

8 December 2022

The inaugural MRC Impact Prize recognises teams who have made outstanding impacts in health and medical research. The winners will be announced at a ceremony in the spring.

Constant genetic surveillance needed to counter multidrug-resistant malaria strains

5 December 2022

Continual monitoring of genetic changes in parasite populations is a powerful tool for analysing malaria outbreaks and identifying emerging multidrug-resistant malaria strains, say researchers from NDM’s Mahidol-Oxford Tropical Medicine Research Unit (MORU).

Lancet study informs WHO guidelines for the treatment of malaria in pregnancy

2 December 2022

The study from the Worldwide Antimalarial Resistance Network (WWARN) provides compelling evidence that artemether-lumefantrine should now replace quinine as the treatment of choice in the first trimester.

New SMRU building opened in Thailand to provide health care to marginalized populations

1 December 2022

The inauguration of a new joint Shoklo Malaria Research Unit (SMRU) and Borderland Health Foundation (BHF) Building took place in Mae Ramat, Thailand, this week.

Research partnership with the University of Navarra agreed

28 November 2022

The Nuffield Department of Medicine and the University of Navarra have entered into a Memorandum of Understanding for collaboration on research and to apply new immunotherapy techniques to cancer patients.

Leedham Lab receives funding to improve bowel cancer treatments

25 November 2022

The Leedham Lab at the Wellcome Centre for Human Genetics in the Nuffield Department of Medicine (NDM) has been awarded over £2m from Cancer Research UK to develop a new tool that could help guide how bowel cancer patients are treated in the future.

Bacterial infections linked to one in eight global deaths, according to GRAM study

22 November 2022

Data showing 7.7 million deaths from 33 bacterial infections can guide measures to strengthen health systems, particularly in low-income settings

Oxford’s Ebola vaccine recommended for deployment against Uganda outbreak

17 November 2022

A vaccine developed by the Oxford Vaccine Group’s Prof Teresa Lambe and supported in clinical trials and manufacture scale-up by researchers from Nuffield Department of Medicine's Jenner Institute has been recommended for inclusion in a ring vaccination trial to combat a Sudan ebolavirus outbreak in Uganda.

New study provides important insights into TB correlates of protection

8 November 2022

Researchers from the Nuffield Department of Medicine’s Jenner Institute have today reported the findings from a study investigating whether previously identified correlates of protection associated with the risk of tuberculosis (TB) disease could also be associated with the risk of infection from the bacteria that causes TB.

Therapeutic HIV vaccine achieves encouraging results

4 November 2022

A phase I/IIa clinical trial that the Nuffield Department of Medicine's Jenner Institute collaborated on has demonstrated that a T-cell therapeutic HIV vaccine was associated with better control of the virus rebound when antiretroviral therapy (ART) was temporarily withdrawn.

Prof James Naismith - Vice President of the Academy of Medical Sciences

Prof James Naismith elected as Academy of Medical Sciences' Vice President

25 October 2022

Established in 1998, the Academy of Medical Sciences is one of the four UK National Academies, coordinating scholarly research activities and standards in the UK.

What's new